Recursion Pharmaceuticals Inc (RXRX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -122.012 | -43.501 | -41.033 | -36.516 | -48.423 |
| Return on Equity (%) | 99.592 | 52.643 | -110.785 | -46.557 | -69.122 |
| Return on Invested Capital (%) | -140.952 | -49.059 | -46.333 | -47.873 | -71.569 |
| Operating Margin (%) | -2640.966 | -2161.686 | -1803.174 | -600.911 | -744.882 |
| Net Profit Margin (%) | -2668.348 | -2196.012 | -1832.177 | -601.049 | -735.987 |
| Book Value Per Share | 5.327 | 16.102 | 1.588 | 1.42 | 0.868 |
| Earnings Per Share | -4.29 | -5.849 | -0.548 | -0.703 | -0.76 |
| Cash Per Share | 4.845 | 17.621 | 0.837 | 1.615 | 0.907 |
| Working Capital Per Share | 4.833 | 16.562 | 1.433 | 1.379 | 0.799 |
| Operating Profit Per Share | 0.161 | 0.266 | 0.03 | 0.01 | 0.061 |
| EBIT Per Share | -4.29 | -5.849 | -0.548 | -0.703 | -0.769 |
| EBITDA Per Share | -4.29 | -5.849 | -0.548 | -0.703 | -0.769 |
| Free Cash Flow Per Share | -4.264 | -5.695 | -0.457 | -0.628 | -0.787 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | 160.91M | 160.91M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | 160.91M | N/A | N/A | N/A | N/A | 230.27M | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -538.223 | N/A | N/A | N/A | -667.914 | N/A | N/A |
| Net Profit Margin (%) | N/A | -538.38 | N/A | N/A | N/A | -662.411 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.94B |
| Price to Earnings Ratio | -6.3 |
| Price to Sales Ratio | 46.37 |
| Price to Cash Ratio | 5.28 |
| Price to Book Ratio | 4.46 |
| Dividend Yield | - |
| Shares Outstanding | 286.64M |
| Average Volume (1 week) | 13.95M |
| Average Volume (1 Month) | 17.04M |
| 52 Week Change | -25.28% |
| 52 Week High | 15.74 |
| 52 Week Low | 5.61 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
